Searched for
NOVO NORDISK CEO EXIT
Microsoft launches firm to help companies adopt AI with $2.5 billionMicrosoft has launched a new venture, Microsoft Frontier Company, backed by $2.5 billion, to guide businesses in selecting and integrating ...- Medical device maker Zimmer Biomet to hire 500 employees in 3 years for tech centre in IndiaMedical device giant Zimmer Biomet is set to significantly expand its Indian footprint by hiring 500 professionals over three years for its...
- Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...
- IndiGo's Chief Human Resources Officer Pasricha resignsIndiGo's Chief Human Resources Officer, Sukhjit Singh Pasricha, has resigned after an eight-year tenure, with Kanwal Jeet Singh Bakshi set ...
- Pi Ventures explores Fund I portfolio exits amid investor scrutiny over returnsWhile Manish Singhal remains a designated “key person” in the fund, Pi Ventures has witnessed several senior-level exits over the past five...
- NRI equity inflow falls; Pi Ventures preps exitsNRI accounts are surging even as stricter compliance and a softer market cool equity inflows. This and more in today’s ETtech Morning Dispa...
- Zee Entertainment gets govt nod for Rs 418-cr investment from Invesco fundZee Entertainment has secured a significant Rs 418 crore foreign investment from OFI Global China Fund LLC, marking the fund's return after...
- Institutional demand sparks surge in block deals as promoters book profitsPromoters and large shareholders are cashing in on a stock market rebound, offloading shares worth over ₹24,000 crore in May and June. This...
- HDFC Bank overhang eases, Kotak CEO exit creates fresh uncertainty: What Pranav Gundlapalle is watching nowIndia's private banking sector faces pivotal moments with two major players at different junctures. HDFC Bank awaits RBI's nod for its CEO,...
- Kotak Mahindra Bank shares fall 3% after CEO's surprise exit. What Nomura, Jefferies saidAnalysts at Nomura and Jefferies, however, maintain 'Buy' ratings, with Nomura highlighting Anup Kumar Saha as a strong internal candidate....
- Ashok Vaswani to step down as Kotak Mahindra Bank MD & CEO; bank begins search for successorIn a surprising announcement, Ashok Vaswani, CEO and Managing Director at Kotak Mahindra Bank, has decided to step down on December 31, 202...
- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
- Is your SIP giving FIIs an easy exit? AMFI CEO says mutual funds will actually lure them backForeign investors have withdrawn over $60 billion from Indian equities, prompting concerns that retail investors are funding their exits. H...
- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- Bombay HC cancels 'Duphachrit' trademark, rules it deceptively similar to Abbott's 'Dupha' familyThe Bombay High Court has cancelled Thane-based Menschlich Healthcare's trademark 'Duphachrit' in favour of Abbott Product Operations AG. T...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- Global Market | European stocks rally as oil falls on hopes for US-Iran dealThe benchmark snapped a four-day losing streak on Thursday, as investors digested the European Central Bank's rate hike and largely looked...
- UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
- Novo Nordisk hit by cyber incident, probes data breachDanish drugmaker Novo Nordisk has confirmed a security incident. Unauthorised access to internal IT systems occurred. Certain non-public da...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
Load More
